Horm Metab Res 2011; 43(02): e1
DOI: 10.1055/s-0030-1268482
Erratum
© Georg Thieme Verlag KG Stuttgart · New York

Somatostatin Analogues do not Aff ect Calcium Metabolism in Patients with Acromegaly and Primary Hyperparathyroidism due to MEN 1-Like Syndrome

Authors

  • F. Bogazzi

    1   Department of Endocrinology, University of Pisa, Pisa, Italy
  • M. Lombardi

    1   Department of Endocrinology, University of Pisa, Pisa, Italy
  • D. Russo

    1   Department of Endocrinology, University of Pisa, Pisa, Italy
  • C. Sardella

    1   Department of Endocrinology, University of Pisa, Pisa, Italy
  • F. Raggi

    1   Department of Endocrinology, University of Pisa, Pisa, Italy
  • S. Brogioni

    1   Department of Endocrinology, University of Pisa, Pisa, Italy
  • F. Cetani

    1   Department of Endocrinology, University of Pisa, Pisa, Italy
  • C. Ceccarelli

    1   Department of Endocrinology, University of Pisa, Pisa, Italy
  • G. Mariani

    2   Department of Oncology, University of Pisa, Pisa, Italy
  • F. Basolo

    3   Department of Surgery, University of Pisa, Pisa, Italy
  • E. Martino

    1   Department of Endocrinology, University of Pisa, Pisa, Italy
Further Information

Publication History

Publication Date:
16 November 2010 (online)

 

Erratum

Somatostatin Analogues do not Affect Calcium Metabolism in Patients with Acromegaly and Primary Hyperthyroidism due to MEN 1-Like Syndrome

F. Bogazzi, M. Lombardi, D. Russo, C. Sardella, F. Raggi, S. Brogioni, F. Cetani, C. Ceccarelli, G. Mariani, F. Basolo, E. Martino

Hormone and Metabolic Research 2010; advance online publication:

DOI: http://dx.doi.org/10.1055/s-0030-1267915

The title was changed after e-first publication to “Somatostatin Analogues do not Affect Calcium Metabolism in Patients with Acromegaly and Primary Hyperparathyroidism due to MEN 1-Like Syndrome”.